Anticoagulant Protein S in COVID-19: The Low Activity Level Is Probably Secondary. | Am J Ther;28(1): e139-e140, 2021. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Anticoagulant Protein S in COVID-19: The Low Activity Level Is Probably Secondary.

Baicus, Cristian; Stoichitoiu, Laura Elena; Pinte, Larisa; Badea, Camelia.

Baicus C; Department of Internal Medicine, Colentina University Hospital Bucharest, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.

Am J Ther ; 28(1): e139-e140, 2021.

Article in English | MEDLINE | ID: covidwho-998554

Subject(s)

COVID-19/blood; Protein S/analysis; COVID-19/complications; Humans; Inflammation/blood; Inflammation/etiology; Lung/pathology; Thrombosis/blood

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Protein S / COVID-19 Topics: Long Covid Limits: Humans Language: English Journal: Am J Ther Journal subject: Therapeutics Year: 2021 Document Type: Article Affiliation country: MJT.0000000000001306

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Protein S / COVID-19 Topics: Long Covid Limits: Humans Language: English Journal: Am J Ther Journal subject: Therapeutics Year: 2021 Document Type: Article Affiliation country: MJT.0000000000001306